Upon binding to its bile acid-derived ligands, S1PR2 potentiates the PI3K/Akt insulin-signaling axis, thereby enhancing peripheral glucose uptake and improving insulin sensitivity, indicating that this receptor–ligand axis constitutes a promising therapeutic target for insulin resistance. This evidence concerns the gene INS and Insulin resistance.